Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...
The biotech's innovative qualities will come in handy. Long gone are the days when Moderna ( MRNA 2.66%) would generate over $18 billion in annual sales from its COVID-19 vaccine. Over the past couple ...
Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.
Zacks Investment Research on MSN
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
The market expects Moderna (MRNA) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc ...
The S&P 500 Healthcare sector (XLV) saw a slight increase in average short interest in September, rising to 1.91% from 1.89% the month prior. Moderna (MRNA) remains the most heavily shorted stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback